Russia and Brazil to partner in production & marketing of Sputnik V vaccine

BRICS partners Russia and Brazil have decided to enter into an agreement to cooperate in the production and marketing of the world’s first registered Coronavirus vaccine Sputnik V by Russia.
Russian Direct Investment Fund has stated that the agreement has been signed with the Brazilian State of Parana. As part of this signed strategic cooperation agreement, the RDIF will work together with the pharma companies in the said Brazilian state for the production of Sputnik V vaccine and its distribution in Brazil and other Latin American countries.
Russia has become the first country to register a vaccine for the COVID 19 named as Sputnik V on August 12.
The vaccine has been developed by Gamaleya Institute, Russian Defence Ministry and the Russian Direct Investment Fund.
This has been registered on August 12 whereas Russia is going to start commercial production of the vaccine within two weeks.